Journal of Clinical Oncology Publishes TREANDA Study Demonstrating Significant Improvement in Overall Response and Progression-Free Survival in Chronic Lymphocytic Leukemia FRAZER, Pa., Aug. 3 -- ...
Phase I-II Study of Oxaliplatin, Fludarabine, Cytarabine, and Rituximab Combination Therapy in Patients With Richter's Syndrome or Fludarabine-Refractory Chronic Lymphocytic Leukemia Seventy-six ...
Skin Reactions: Skin reactions have been reported with bendamustine hydrochloride treatment including rash, toxic skin reactions, and bullous exanthema. In a study of bendamustine hydrochloride (90 mg ...
This leaflet answers some common questions about BENDAMUSTINE VIATRIS. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All ...
SymBio Pharmaceuticals Limited has announced that it has initiated a phase 2 clinical trial for its lead drug candidate, bendamustine hydrochloride (SyB L-0501), in previously untreated multiple ...
Case Name: In re Bendamustine Consolidated Cases, Civ. No. 13-2046-GMS, 2015 U.S. Dist. LEXIS 55963 (D. Del. Apr. 29, 2015) (Sleet, J.) Drug Product and Patent(s)-in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback